Citations are generated automatically from bibliographic data as a convenience and may not be complete or accurate.
U.S. Congress. House. Affirming the importance of the Orphan Drug Act, celebrating the over 750 new orphan therapies approved since its creation, and recognizing the need to continue supporting research and development for rare diseases. H. Res. 242. 116th Cong., 1st sess., Introduced in House March 18, 2019. https://www.govinfo.gov/app/details/BILLS-116hres242ih.
Congress, House of Representatives (2019, March 18). Affirming the importance of the Orphan Drug Act, celebrating the over 750 new orphan therapies approved since its creation, and recognizing the need to continue supporting research and development for rare diseases. (H. Res. 242 (IH)). Retrieved from https://www.govinfo.gov/app/details/BILLS-116hres242ih.
United States, Congress, House of Representatives. Affirming the importance of the Orphan Drug Act, celebrating the over 750 new orphan therapies approved since its creation, and recognizing the need to continue supporting research and development for rare diseases. U.S. Government Publishing Office, https://www.govinfo.gov/app/details/BILLS-116hres242ih. 116th Congress, H. Res. 242, Introduced in House 18 Mar. 2019.
H.Res.242 - 116th Congress (2019-2020): Affirming the importance of the Orphan Drug Act, celebrating the over 750 new orphan therapies approved since its creation, and recognizing the need to continue supporting research and development for rare diseases., H.Res.242, 116th Cong. (2019), https://www.govinfo.gov/app/details/BILLS-116hres242ih.